Rising Focus on Rare Disease Treatment Creates Opportunities for Recombinant Coagulation Therapies
Rare diseases are receiving increasing attention from pharmaceutical companies, healthcare organizations, and biotechnology researchers. Although individual rare conditions affect relatively small patient populations, their treatment requirements can be complex and highly specialized. Inherited coagulation disorders are an important example, creating demand for therapies that address specific...
0 Commentaires 0 Parts 61 Vue 0 Aperçu